ResultsIQ › Latest results › Anlon Healthcare Limited
Anlon Healthcare Limited Q2 FY27 earnings call summary
NSE: AHCL · BSE: 544497
Earnings call of 3 Nov 2026, summarised by AI from the filing.
Rajkot greenfield adds ~1,200 MTPA through 8 clean lines, commissioning Q1 FY28, with revenue from Q2 FY28.
Key takeaways
- Capacity Rajkot greenfield adds ~1,200 MTPA through 8 clean lines, commissioning Q1 FY28, with revenue from Q2 FY28.
- Raw material Raw material prices have not normalised and remain at post-war levels, keeping margin below the guided band.
Anlon Healthcare Limited Q2 FY27 results
As filed: Revenue ₹106 cr, EBITDA ₹25.2 cr, PAT ₹17.2 cr, EBITDA margin 23.9%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹106 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹31.0 cr (−6% year on year), EBITDA ₹7.5 cr (+24% year on year), PAT ₹4.8 cr (+20% year on year), EBITDA margin 24.1% (+590 bps). Score 53 of 100, In line with trend. EBITDA margin rose 590 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 44% from last quarter. Share price after the results: +0.2% in 29 days (Nifty 500: +0.8%).
- Q4 FY26: Revenue ₹55.4 cr, EBITDA ₹13.9 cr, PAT ₹9.8 cr, EBITDA margin 25.1%. Not scored. No result for the same quarter last year. Share price after the results: +14.3% in 27 days (Nifty 500: +0.6%).
- Q3 FY26: Revenue ₹35.6 cr, EBITDA ₹12.3 cr, PAT ₹5.2 cr, EBITDA margin 34.7%. Not scored. No result for the same quarter last year. Share price after the results: +0.9% in 30 days (Nifty 500: −6.9%).
- Q2 FY26: Revenue ₹52.0 cr, EBITDA ₹13.0 cr, PAT ₹9.0 cr, EBITDA margin 25.0%. Not scored. No result for the same quarter last year. Share price after the results: −0.8% in 30 days (Nifty 500: −0.2%).
- Q1 FY26: Revenue ₹33.0 cr, EBITDA ₹6.0 cr, PAT ₹4.0 cr, EBITDA margin 18.2%. Not scored. No result for the same quarter last year.
Past price moves after results do not indicate future moves. Not a recommendation.
Anlon Healthcare Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (3 Nov 2026), Results deck (30 Oct 2026)
- Q1 FY27: Earnings call (6 Aug 2026), Results deck (5 Aug 2026), Results press release (31 Jul 2026)
- Q4 FY26: Earnings call (3 Jun 2026), Results deck (3 Jun 2026), Results press release (29 May 2026)
- Q3 FY26: Earnings call (19 Feb 2026), Results deck (19 Feb 2026)
- Q2 FY26: Earnings call (19 Nov 2025), Results deck (19 Nov 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.